A Study in Parkinson's Disease in Patients With Moderate to Severe Dyskinesia
Clinical trial NCT03956979 · COMPLETED
Trial details
- NCT number
- NCT03956979
- Sponsor
- Contera Pharma
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-22
- Primary completion
- 2024-03-07
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.